Delivery Order SPE2DB24D2109-SPE2DB25FHXRD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a $34,669.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of July 24, 2025. This competitively awarded contract, issued on July 23, 2025, carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $16,283.25 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order, awarded on August 1, 2025, represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,153.78 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 12, 2025, for the supply of Betaseron 0.3 mg kits valued at $16,778.88. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with DLA, which procures medical supplies...
- The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits with a ceiling value of $82,716.10 under a firm fixed-price contract type. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,433.32 firm-fixed-price contract is for the supply of BETASERON 0.3 MG KITS, a specialty medication product. The contract has a period of performance through February 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXRDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Betaseron 0.3 mg kits with a contract value of $36,290.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency requirements and other government healthcare systems, demonstrating the contractor's extensive capability to fulfill federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.3k | 8/8/25 |